Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891618-97-001304
Filing Date
1997-03-24
Accepted
1997-03-24 00:00:00
Documents
15
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR YEAR ENDING 12/31/96 10-K 139556
2 AMENDMENT TO 1992 DIRECTOR OPTION PLAN EX-10.08 2516
3 AMENDMENT TO 1992 DIRECTOR OPTION PLAN EX-10.09 1685
4 AMENDMENT TO 401(K) PLAN EX-10.11 7015
5 LEASE AMENDMENT FO THE COMPANY'S OFFICES EX-10.14 13424
6 LEASE AGREEMENT FOR THE COMPANY'S OFFICES EX-10.16 91231
7 LEASE AMENDMENT FOR THE COMPANY'S OFFICES EX-10.17 5920
8 LEASE AMENDMENT FOR THE COMPANY'S OFFICES EX-10.18 3224
9 LOAN MODIFICATION AGREEMENT EX-10.24 9604
10 LOAN MODIFICATION AGREEMENT EX-10.25 20243
11 MASTER LEASE PURCHASE AGREEMENT EX-10.32 60662
12 MASTER EQUIPMENT LEASE DATED MARCH 17,1996 EX-10.33 23283
13 LIST OF SUBSIDIARIES EX-21.01 278
14 CONSENT OF ARTHUR ANDERSEN LLP EX-23.01 533
15 FINANCIAL DATA SCHEDULE EX-27.1 2153
  Complete submission text file 0000891618-97-001304.txt   384247
Mailing Address
Business Address 1505 A OBRIEN DR MENLO PARK CA 94025 4153286200
PHARMCHEM LABORATORIES INC (Filer) CIK: 0000876645 (see all company filings)

EIN.: 770187280 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19371 | Film No.: 97560721
SIC: 8071 Services-Medical Laboratories